Résumé
Infiltration of the prostatic ducts by prostatic adenocarcinoma occurs relatively frequently, being most commonly associated with high grade disease. It is now recognised that intraductal carcinoma of the prostate (IDCP) has an associated poor prognosis and this is reflected in its histological, molecular and immunohistochemical features. The current recommendation of the World Health Organization is that IDCP not be taken into consideration when grading prostate adenocarcinoma. It is apparent that Gleason did not differentiate between IDCP and stromal invasive carcinoma when developing and validating his grading system, and recent studies suggest that the incorporation of IDCP grading into the overall grading of the specimen provides additional prognostic information.
Langue d'origine | English |
---|---|
Pages (de-à) | 192-196 |
Nombre de pages | 5 |
Journal | Pathology |
Volume | 52 |
Numéro de publication | 2 |
DOI | |
Statut de publication | Published - févr. 2020 |
Publié à l'externe | Oui |
Note bibliographique
Publisher Copyright:© 2019 Royal College of Pathologists of Australasia
ASJC Scopus Subject Areas
- Pathology and Forensic Medicine